Dublin, Nov. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Cell Expansion Global Market - Forecast to 2022" report to their offering. The cell expansion market is expected to grow at a double digit CAGR to reach $23,997 million by 2022
Among the cell expansion products, the consumables dominated the market by occupying a largest share and instruments market is estimated to be the fastest growing segment from 2015 to 2022. In cell types, human cell types is the largest segment as well as the fastest growing segment. In applications, the regenerative medicine and stem cell research is the largest segment and is the fastest growing segment with a highest CAGR of 18.1% from 2015-2022. By end- users, hospitals and bio banks are the largest segment with a share of 37.0% and also, the fastest segment from 2015 to 2022.
Rising prevalence of chronic diseases, increasing government funding for research, increased investments in cell based products, growing number of GMP-certified production facilities and 3D cell expansion technology are some of the drivers in the cell expansion global market. High cost of cell-based research, use of unregulated products, quality issues for end users, ethical concerns regarding research on cell biology and stringent regulation are some of the factors hampering the market. The cell expansion global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.
Some of the key players of the cell expansion market are
- Becton Dickinson and Company (U.S.)
- Corning, Inc. (U.S.)
- Danaher Corporation (U.S.)
- Eppendorf AG (Germany)
- GE Healthcare (U.K)
- Lonza Group Ltd. (Switzerland)
- Merck KGAA (Germany.)
- Miltenyi Biotec (Germany)
- STEMCELL Technologies (Canada)
- Terumo Corporation (Japan)
- ThermoFisher Scientific Inc. (U.S.)
Key Topics Covered: 1 Executive Summary
2 Introduction 3 Market Analysis 3.1 Introduction 3.2 Market Segmentation 3.3 Factors Influencing Market 3.3.1 Drivers And Opportunities 3.3.1.1 Rising Prevalence Of Chronic Diseases 3.3.1.2 Increasing Government Funding For Research 3.3.1.3 Increased Investments In Cell Based Research 3.3.1.4 Growing Number Of Gmp-Certified Production Facilities. 3.3.1.5 3D Cell Expansion Technology 3.3.1.6 Countries In Asia-Pacific Region To Present High-Growth Opportunities 3.3.2 Restraints And Threats 3.3.2.1 High Cost Of Cell-Based Products 3.3.2.2 Use Of Unregulated Products 3.3.2.3 Quality Issues For End Users 3.3.2.4 Ethical Concerns Regarding Research On Cell Biology 3.3.2.5 Stringent Regulation 3.4 Porter's Five Force Analysis 3.5 Regulatory Guidelines 3.6 Upcoming Technologies 3.7 Supply Chain Analysis 3.8 Market Share Analysis By Major Players 3.9 Patent Trends
4 Cell Expansion Global Market, By Products 4.1 Introduction 4.2 Instruments 4.2.1 Cell Expansion Supporting Equipments 4.2.1.1 Flow Cytometers 4.2.1.2 Centrifuge 4.2.1.3 Cell Counters 4.2.1.4 Other Cell Expansion Supporting Equipments 4.2.2 Bioreactors 4.2.2.1 Stirred Type Bioreactors 4.2.2.2 Microcarrier-Based Anchorage-Dependent Stirred Type Bioreactors 4.2.2.3 Suspension-Based Anchorage Independent Stirred Type Bioreactors 4.2.2.4 Hollow Fiber/Perfusion Bioreactors 4.2.2.5 Bubble Column And Airlift Bioreactors 4.2.2.6 Single Use/Disposabable Bioreactors 4.2.2.7 Other Bioreactors 4.2.3 Automated Cell Expansion Systems 4.3 Consumables 4.3.1 Reagents, Media And Sera 4.3.2 Disposables 4.3.2.1 Culture Vessels 4.3.2.2 Bioreactor Accessories 4.3.2.3 Others
5 Cell Expansion Market, By Types 5.1 Introduction 5.2 Animal Cell 5.3 Human Cell 5.3.1 Adult Stem Cell 5.3.1.1 Neural Stem Cells (NSCS) 5.3.1.2 Hematopoietic Stem Cells (HSCS) 5.3.1.3 Mesenchymal Stem Cells (MSC) 5.3.2 Induced Pluripotent Stem Cell (IPSC) 5.3.3 Embryonic Stem Cell 5.4 Bacterial Cells 5.5 Others
6 Cell Expansion Global Market, By Applications 6.1 Introduction 6.2 Regenerative Medicine And Stem Cell Research 6.3 Cancer Studies 6.4 Others
7 Cell Expansion Global Market, By End Users 7.1 Introduction 7.2 Academic And Research Institutes 7.3 Biotechnology And Biopharmaceutical Company 7.4 Hospitals And Bio Banks 7.5 Others
8 Regional Market Analysis
9 Company Developments 9.1 Introduction 9.2 New Product Launch 9.3 Agreements Parterner Ships, Collaborations & Joint Ventures 9.4 Other Developments 9.5 Merger And Acqisition
10 Company Profiles
Companies Featured:
- 300Microns Gmbh
- Abec Inc
- Acea Bioscience, Inc
- Alere Inc
- Antigen America Inc.
- Applikon Biotechnologies
- Auxilab S.L
- Axol Bioscience
- Bbi Biotec
- Becton, Dickinson And Company
- Biological Industry
- Biomerieux
- Bioreactor Sciences
- Cell Applications, Inc.
- Cellgenix
- Celltreat Scientific Products
- Celprogen Inc
- Chemometec Usa Inc
- Cole Parmer
- Corning, Inc.
- Danaher Corporation
- Diagenode S.A
- Eppendorf AG
- Fineesse
- Flownamics
- GE Healthcare
- Genlantis
- Haier
- Handyem
- Hettich Lab Technology
- Hi-Media
- Hitachi
- Hurel Corporation
- IBA
- Infors HT
- Inoxcva
- Leica Biosystems
- Logos Biosystems
- Lonza Group Ltd.
- Memmert Gmbh
- Merck KGAA
- Miltenyi Biotec
- Molecular Devices
- Olympus Corporation
- Pall Corporation
- PBS Biotech
- Percell Biolytica AB
- Prodizen, Inc.
- R&D Systems
- Reachbio Llc
- Reinnervate
- Roosterbio
- RR Mechetronics
- Sartorious AG
- Stembiosys
- Stemcell Technologies
- Sunrise Science Products, Inc.
- Synthecon
- Sysmex
- Takara Bio
- Terumo Corporation
- Thermo Fisher Scientific
- Toyo Gosei Co., Ltd
- Vision Scientific Co Ltd
- Vivo Biosciences Inc.
- Zen-Bio Inc
For more information about this report visit http://www.researchandmarkets.com/research/6n..._expansion
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Biotechnology
